174 related articles for article (PubMed ID: 24049712)
1. Effective Arrestin-Specific Immunotherapy of Experimental Autoimmune Uveitis with RTL: A Prospect for Treatment of Human Uveitis.
Kyger M; Worley A; Huan J; McDowell H; Smith WC; Burrows GG; Mattapallil MJ; Caspi RR; Adamus G
Transl Vis Sci Technol; 2013 Feb; 2(2):1. PubMed ID: 24049712
[TBL] [Abstract][Full Text] [Related]
2. A humanized model of experimental autoimmune uveitis in HLA class II transgenic mice.
Pennesi G; Mattapallil MJ; Sun SH; Avichezer D; Silver PB; Karabekian Z; David CS; Hargrave PA; McDowell JH; Smith WC; Wiggert B; Donoso LA; Chan CC; Caspi RR
J Clin Invest; 2003 Apr; 111(8):1171-80. PubMed ID: 12697736
[TBL] [Abstract][Full Text] [Related]
3. [Effects of leflunomide on experimental autoimmune uveitis in Lewis rats].
Fang C; Zhou D; Zhan S; He Y; Lin Z; Huang C; Li J
Zhonghua Yan Ke Za Zhi; 2015 Oct; 51(10):754-61. PubMed ID: 26693771
[TBL] [Abstract][Full Text] [Related]
4. KS23, a novel peptide derived from adiponectin, inhibits retinal inflammation and downregulates the proportions of Th1 and Th17 cells during experimental autoimmune uveitis.
Niu T; Cheng L; Wang H; Zhu S; Yang X; Liu K; Jin H; Xu X
J Neuroinflammation; 2019 Dec; 16(1):278. PubMed ID: 31883532
[TBL] [Abstract][Full Text] [Related]
5. Induction of antigen-specific Treg cells in treating autoimmune uveitis via bystander suppressive pathways without compromising anti-tumor immunity.
Chen Z; Zhang T; Kam HT; Qiao D; Jin W; Zhong Y; Zhou M; Zhou H; Chong WP; Chen W; Chen J
EBioMedicine; 2021 Aug; 70():103496. PubMed ID: 34280776
[TBL] [Abstract][Full Text] [Related]
6. S-nitrosoglutathione prevents interphotoreceptor retinoid-binding protein (IRBP(161-180))-induced experimental autoimmune uveitis.
Haq E; Rohrer B; Nath N; Crosson CE; Singh I
J Ocul Pharmacol Ther; 2007 Jun; 23(3):221-31. PubMed ID: 17593005
[TBL] [Abstract][Full Text] [Related]
7. Deficiency of IL-27 Signaling Exacerbates Experimental Autoimmune Uveitis with Elevated Uveitogenic Th1 and Th17 Responses.
Wu S; Ma R; Zhong Y; Chen Z; Zhou H; Zhou M; Chong W; Chen J
Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299138
[TBL] [Abstract][Full Text] [Related]
8. Activation of liver X receptor alleviates ocular inflammation in experimental autoimmune uveitis.
Yang H; Zheng S; Qiu Y; Yang Y; Wang C; Yang P; Li Q; Lei B
Invest Ophthalmol Vis Sci; 2014 Apr; 55(4):2795-804. PubMed ID: 24699378
[TBL] [Abstract][Full Text] [Related]
9. Upregulation of DR3 expression in CD4⁺ T cells promotes secretion of IL-17 in experimental autoimmune uveitis.
Qin T
Mol Vis; 2011; 17():3486-93. PubMed ID: 22219644
[TBL] [Abstract][Full Text] [Related]
10. Dynamics of intraocular IFN-γ, IL-17 and IL-10-producing cell populations during relapsing and monophasic rat experimental autoimmune uveitis.
Kaufmann U; Diedrichs-Möhring M; Wildner G
PLoS One; 2012; 7(11):e49008. PubMed ID: 23155443
[TBL] [Abstract][Full Text] [Related]
11. Tofacitinib inhibits the development of experimental autoimmune uveitis and reduces the proportions of Th1 but not of Th17 cells.
Bing SJ; Lyu C; Xu B; Wandu WS; Hinshaw SJ; Furumoto Y; Caspi RR; Gadina M; Gery I
Mol Vis; 2020; 26():641-651. PubMed ID: 33088168
[TBL] [Abstract][Full Text] [Related]
12. A promising therapeutic approach for treatment of posterior uveitis: recombinant T cell receptor ligand protects Lewis rats from acute and recurrent experimental autoimmune uveitis.
Adamus G; Karren LJ; Mooney J; Burrows GG
Ophthalmic Res; 2010; 44(1):24-33. PubMed ID: 20145422
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of Th17 differentiation by anti-TNF-alpha therapy in uveitis patients with Behçet's disease.
Sugita S; Kawazoe Y; Imai A; Yamada Y; Horie S; Mochizuki M
Arthritis Res Ther; 2012 May; 14(3):R99. PubMed ID: 22546542
[TBL] [Abstract][Full Text] [Related]
14. CTLA4-Ig suppresses development of experimental autoimmune uveitis in the induction and effector phases: Comparison with blockade of interleukin-6.
Iwahashi C; Fujimoto M; Nomura S; Serada S; Nakai K; Ohguro N; Nishida K; Naka T
Exp Eye Res; 2015 Nov; 140():53-64. PubMed ID: 26297802
[TBL] [Abstract][Full Text] [Related]
15. Peripheral expression of rod photoreceptor arrestin induces an epitope-specific, protective response against experimental autoimmune uveoretinitis.
McPherson SW; Roberts JP; Gregerson DS
Curr Eye Res; 2005 Jun; 30(6):491-502. PubMed ID: 16020282
[TBL] [Abstract][Full Text] [Related]
16. Amelioration of experimental autoimmune uveitis by leflunomide in Lewis rats.
Fang CB; Zhou DX; Zhan SX; He Y; Lin Z; Huang C; Li J
PLoS One; 2013; 8(4):e62071. PubMed ID: 23626769
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of T cell-mediated inflammation in uveitis by a novel anti-CD3 antibody.
Sugita S; Shimizu J; Makabe K; Keino H; Watanabe T; Takahashi M
Arthritis Res Ther; 2017 Jul; 19(1):176. PubMed ID: 28743289
[TBL] [Abstract][Full Text] [Related]
18. Treatment of autoimmune anterior uveitis with recombinant TCR ligands.
Adamus G; Burrows GG; Vandenbark AA; Offner H
Invest Ophthalmol Vis Sci; 2006 Jun; 47(6):2555-61. PubMed ID: 16723470
[TBL] [Abstract][Full Text] [Related]
19. Regulatory effects of IFN-β on the development of experimental autoimmune uveoretinitis in B10RIII mice.
Sun M; Yang Y; Yang P; Lei B; Du L; Kijlstra A
PLoS One; 2011 May; 6(5):e19870. PubMed ID: 21573074
[TBL] [Abstract][Full Text] [Related]
20. Longdan Xiegan Decoction alleviates experimental autoimmune uveitis in rats by inhibiting Notch signaling pathway activation and Th17 cell differentiation.
Yin X; Qiu Y; Li Z; Guo L; Wei H; Liu B; Zhou M; Li T; Wang L; Jiang W; Bi H; Guo D
Biomed Pharmacother; 2021 Apr; 136():111291. PubMed ID: 33493870
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]